These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 8503575)
21. Bronchoalveolar lavage cell analysis in sarcoidosis. A comparison of lymphocyte counts and clinical course. Buchalter S; App W; Jackson L; Chandler D; Jackson R; Fulmer J Ann N Y Acad Sci; 1986; 465():678-84. PubMed ID: 3460403 [No Abstract] [Full Text] [Related]
22. [The evaluation of the Kveim test in sarcoidosis diagnostics for out-patients (author's transl)]. Zaumseil I; Eckert H; Djurić B; Krüger A Z Erkr Atmungsorgane; 1976 May; 145(2):183-9. PubMed ID: 983175 [TBL] [Abstract][Full Text] [Related]
23. [Mediastinal-pulmonary sarcoidosis with unilateral pseudotumorous presentation. Apropos of a case]. Vuillermoz S; Bayle JY; Perol M; Arnouk H; Guerin JC Rev Mal Respir; 1992; 9(6):641-3. PubMed ID: 1470761 [TBL] [Abstract][Full Text] [Related]
24. Elevated serum immunoglobulin G levels and bronchoalveolar lymphocytosis as predictors of clinical course in pulmonary sarcoidosis. Bell DY; Johnson SM; Piantadosi CA Ann N Y Acad Sci; 1986; 465():672-7. PubMed ID: 3460402 [No Abstract] [Full Text] [Related]
28. [Therapy of sarcoidosis]. Christ R; Eule H; Wiesner B; Weinecke A; Ballin A; Thomas E; Eckert H Z Erkr Atmungsorgane; 1988; 170(3):314-6. PubMed ID: 3188591 [No Abstract] [Full Text] [Related]
29. The prognosis of early sarcoidosis. Douglas AC Acta Med Scand Suppl; 1964; 425():284-6. PubMed ID: 5884506 [No Abstract] [Full Text] [Related]
30. Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis. Gluskowski J; Hawrylkiewicz I; Zych D; Zieliński J Eur Respir J; 1990 Apr; 3(4):403-7. PubMed ID: 2365034 [TBL] [Abstract][Full Text] [Related]
31. Corticosteroid treatment of sarcoidosis--who needs it? Israel HL N Y State J Med; 1987 Sep; 87(9):490. PubMed ID: 2444910 [No Abstract] [Full Text] [Related]
33. [Points of view on the treatment of sarcoidosis]. Bercea O; Stoicescu P Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(3):207-12. PubMed ID: 2559455 [No Abstract] [Full Text] [Related]
34. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med; 1999 Aug; 160(2):736-55. PubMed ID: 10430755 [No Abstract] [Full Text] [Related]
35. [Characteristics of the clinical course of pulmonary sarcoidosis in middle-aged patients]. Bukhalovskiĭ IN; Uspenskiĭ SP; Aivaz'ian SV; Rakova GM Sov Med; 1985; (12):108-10. PubMed ID: 4095619 [No Abstract] [Full Text] [Related]
37. Notes on the management of endothoracic sarcoidosis with ACTH. Mariani B Panminerva Med; 1977; 19(5):345-52. PubMed ID: 202909 [No Abstract] [Full Text] [Related]
38. A better use of corticosteroids. Andrews R; Lightman S Practitioner; 2000 Aug; 244(1613):667. PubMed ID: 11042932 [No Abstract] [Full Text] [Related]
39. [Effectiveness of various schedules of drug therapy of patients with sarcoidosis of the respiratory organs]. Ozerova LV; Stepanian IE; Romanov VV; Kireeva TA Probl Tuberk; 1989; (3):37-41. PubMed ID: 2726708 [TBL] [Abstract][Full Text] [Related]
40. [Progress in studies on sarcoidosis]. Krychniak W; Zych D Pneumonol Pol; 1983 Oct; 51(10):489-92. PubMed ID: 6657488 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]